Publicaciones en colaboración con investigadores/as de Harvard Medical School (3)

2021

  1. ERK inhibitor LY3214996-based treatment strategies for RAS-driven lung cancer

    Molecular Cancer Therapeutics, Vol. 20, Núm. 4, pp. 641-654

2019

  1. Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF

    Cancer Cell, Vol. 35, Núm. 4, pp. 573-587.e6

2014

  1. STAT3 beta controls inflammatory responses and early tumor onset in skin and colon experimental cancer models

    AMERICAN JOURNAL OF CANCER RESEARCH, Vol. 4, Núm. 5, pp. 484-494